Atlas Trials

Safety and Tolerability of Rituximab in Neuromyelitis Optica

Clinical trial NCT00501748 · COMPLETED

Trial details

NCT number
NCT00501748
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neuromyelitis Optica
Start date
2004-01-01
Primary completion
2010-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.